Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Nadolol block of Nav1.5 does not explain its efficacy in the long QT syndrome.
Besana A, Wang DW, George AL Jr, Schwartz PJ.
J Cardiovasc Pharmacol. 2012 Mar;59(3):249-53.
Related citations
Spironolactone prevents the inducibility of ventricular tachyarrhythmia in rats with aldosteronism.
Deshmukh PA, Bellary SR, Schwender FT, Kamalov G, Magotra M, de Jongh Curry AL, Sun Y, Weber KT.
J Cardiovasc Pharmacol. 2011 Nov;58(5):487-91.
Atrial fibrillation and atrial fibrosis.
Tan AY, Zimetbaum P.
J Cardiovasc Pharmacol. 2011 Jun;57(6):625-9. Review.
Fibrosis and cardiac arrhythmias.
de Jong S, van Veen TA, van Rijen HV, de Bakker JM.
J Cardiovasc Pharmacol. 2011 Jun;57(6):630-8. Review.
Effect of herbal consumption on time in therapeutic range of warfarin therapy in patients with atrial fibrillation.
Chan HT, So LT, Li SW, Siu CW, Lau CP, Tse HF.
J Cardiovasc Pharmacol. 2011 Jul;58(1):87-90.
Drug-induced QTC prolongation dangerously underestimates proarrhythmic potential: lessons from terfenadine.
Hondeghem LM, Dujardin K, Hoffmann P, Dumotier B, De Clerck F.
J Cardiovasc Pharmacol. 2011 May;57(5):589-97.
Reduced antiarrhythmic efficacy of verapamil in isolated rat hearts in the presence of elevated extracellular calcium.
Lieu PB, Fornari M, Ramos T, Hatcher AS, Clements-Jewery H.
J Cardiovasc Pharmacol. 2011 Apr;57(4):455-62.
The cardiac fibroblast: functional and electrophysiological considerations in healthy and diseased hearts.
Vasquez C, Benamer N, Morley GE.
J Cardiovasc Pharmacol. 2011 Apr;57(4):380-8. Review.
Wogonin suppresses arrhythmias, inflammatory responses, and apoptosis induced by myocardial ischemia/reperfusion in rats.
Lee YM, Cheng PY, Chen SY, Chung MT, Sheu JR.
J Cardiovasc Pharmacol. 2011 Aug;58(2):133-42.
The duration of pacing-induced atrial fibrillation is reduced in vivo by inhibition of small conductance Ca(2+)-activated K(+) channels.
Skibsbye L, Diness JG, Sørensen US, Hansen RS, Grunnet M.
J Cardiovasc Pharmacol. 2011 Jun;57(6):672-81.
Mitochondrial uncoupling agents trigger ventricular fibrillation in isolated rat hearts.
Hatcher AS, Alderson JM, Clements-Jewery H.
J Cardiovasc Pharmacol. 2011 Apr;57(4):439-46.
Atrial Fibrillation and Atrial Fibrosis.
J Cardiovasc Pharmacol. 2010 Dec 4. [Epub ahead of print]
The role of microRNA in cardiac excitability.
Wang Z.
J Cardiovasc Pharmacol. 2010 Nov;56(5):460-70. Review.
Rescue of mutated cardiac ion channels in inherited arrhythmia syndromes.
Balijepalli SY, Anderson CL, Lin EC, January CT.
J Cardiovasc Pharmacol. 2010 Aug;56(2):113-22. Review.
Effects of sex hormones on cardiac repolarization.
Yang PC, Clancy CE.
J Cardiovasc Pharmacol. 2010 Aug;56(2):123-9. Review.
The cardiac pacemaker and conduction system develops from embryonic myocardium that retains its primitive phenotype.
Bakker ML, Christoffels VM, Moorman AF.
J Cardiovasc Pharmacol. 2010 Jul;56(1):6-15. Review.
The right stuff in the right place-the quest for atrial selective antiarrhythmic agents.
Lazzara R.
J Cardiovasc Pharmacol. 2010 Jul;56(1):78-9. No abstract available.
The mechanism of the negative chronotropic and dromotropic actions of adenosine 5'-triphosphate in the heart: an update.
Pelleg A, Belhassen B.
J Cardiovasc Pharmacol. 2010 Jul;56(1):106-9. Review.
Comparison of thiopental, urethane, and pentobarbital in the study of experimental cardiology in rats in vivo.
Zorniak M, Mitrega K, Bialka S, Porc M, Krzeminski TF.
J Cardiovasc Pharmacol. 2010 Jul;56(1):38-44.
Cardiovascular effects of a novel synthetic analogue of naturally occurring piperamides.
de Araújo Júnior JX, Julien C, Barrès C, de Medeiros IA, Ribeiro EA, Lima LM, Barreiro EJ.
J Cardiovasc Pharmacol. 2010 Sep;56(3):293-9.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on